Medical Procurement of Ukraine (MPU) and the international pharmaceutical company Roche have entered into an investment agreement to localize the manufacturing of oncology medicines in Ukraine.
This landmark agreement was formalised by official representatives at the 4th Annual International Ukraine Recovery Conference – Ukraine Recovery Conference 2025 held in Rome (Italy) in July. For the first time, MPU becomes a full-fledged partner of a global leader in the development of innovative medicines. Read more.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
